Affiliation
Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, UK.Issue Date
2013-05-25
Metadata
Show full item recordCitation
Breast cancer prevention: SERMs come of age. 2013, 381 (9880):1795-7 LancetJournal
LancetDOI
10.1016/S0140-6736(13)60443-2PubMed ID
23639489Type
ArticleLanguage
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(13)60443-2
Scopus Count
Collections
Related articles
- Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence.
- Authors: Buzdar AU
- Issue date: 2013 Sep 17
- Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
- Authors: Lewis JS, Jordan VC
- Issue date: 2005 Dec 11
- [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
- Authors: Ricart JJ
- Issue date: 2004
- Raloxifene examined for breast cancer prevention.
- Authors: Young D
- Issue date: 2007 Sep 1
- Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
- Issue date: 2006 Oct